Sumitomo Pharma Co Ltd 2018 IR

The report outlines Sumitomo Dainippon Pharma's financial and sustainability performance for fiscal year 2017. Key achievements include record-high consolidated revenue of 466.8 billion yen and the completion of the world's first commercial manufacturing plant for allogeneic iPS cell-derived regenerative medicine products. The company restructured its R&D framework into the Drug Research Division to accelerate drug discovery in its focus areas of psychiatry, neurology, oncology, and regenerative medicine. Additionally, the company advanced its CSR-based management by conducting a materiality assessment, promoting work style innovations, and participating in the global Access Accelerated initiative to improve healthcare access in developing countries.

Company: Sumitomo Pharma Co Ltd

Sector: Health Care

Country: Japan

Year: 2018

Type: IR

Pages: 138

Back to company

Sumitomo Pharma Co Ltd

Sumitomo Pharma Co Ltd 2018 Integrated Report

Integrated Report

The report outlines Sumitomo Dainippon Pharma's financial and sustainability performance for fiscal year 2017. Key achievements include record-high consolidated revenue of 466.8 billion yen and the completion of the world's first commercial manufacturing plant for allogeneic iPS cell-derived regenerative medicine products. The company restructured its R&D framework into the Drug Research Division to accelerate drug discovery in its focus areas of psychiatry, neurology, oncology, and regenerative medicine. Additionally, the company advanced its CSR-based management by conducting a materiality assessment, promoting work style innovations, and participating in the global Access Accelerated initiative to improve healthcare access in developing countries.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2018

Reporting Period

Apr 1, 2017 - Mar 31, 2018

Fiscal Year

2017

Type

Integrated Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Energy Consumption

Total Waste

Women in Management

Employees